Progress in the Impact of Nutritional Intervention on Improving Elderly T2DM Patients With Muscle Atrophy

Zhuobin Jia

doi:10.54097/mhqmav74

Authors

Zhuobin Jia

DOI:

https://doi.org/10.54097/mhqmav74

Keywords:

Type 2 diabetes mellitus; elderly patients; nutritional intervention.

Abstract

With the aging of the population, the number of elderly patients with Type 2 diabetes mellitus (T2DM) is increasing, and it often coexists with sarcopenia due to common pathological and physiological basis. In recent years, the pathogenesis of the combination of the two has been continuously explored, diagnostic methods have been continuously improved, and treatment plans have been expanded in both drug and non drug aspects. This study aims to explore the effectiveness of different nutritional interventions on elderly T2DM patients with muscle atrophy through clinical trials and observational studies, providing scientific basis for clinical practice. While implementing nutritional interventions, this study will focus on patient safety, evaluate the potential side effects of intervention measures, and ensure that patients do not face additional health risks during the treatment process. By studying the effects of nutritional interventions, this study aims to provide guidance and recommendations for clinical doctors, as well as a basis for policy makers, to promote the management and treatment of sarcopenia in elderly T2DM patients, improve their quality of life, increase muscle mass and function, reduce complications, and enhance their self-care ability.

Downloads

Download data is not yet available.

References

[1] Zhu Yanyuan, Zhu Jingyi, Bai Jiaojiao. Research progress of exercise and nutrition intervention in elderly type 2 diabetes patients with myopenia. Shanghai Nursing, 2024, 24(09): 19-22.

[2] Halling JF, Pilegaard H. PGC-1α-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab, 2020, 45(9): 927-936.

[3] Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci, 2017, 18(6): 1321.

[4] Li Na, Han Yubo, Yao Chunli, et al. Research progress on the relationship between mitochondrial dysfunction and insulin resistance. Chinese Journal of Medicine, 2024, 19(12): 1888-1892.

[5] Ridker PM, Rane M. Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease. Circ Res, 2021, 128(11): 1728-1746.

[6] Hailemichael Y, Johnson DH, Abdel-Wahab N, et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell, 2022, 40(5): 509-523.

[7] Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in longterm hemodialysis patients. Am J Kidney Dis, 2003, 42(2): 295-302?

[8] Jang DI, Lee AH, Shin HY, et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci, 2021, 22(5): 2719.

[9] He SD, Zhang L, Yu SY, et al. Association between tumor necrosis factor-alpha (TNF-α) polymorphisms and schizophrenia: An updated meta-analysis. Int J Psychiatry Clin Pract, 2022, 26(3): 294-302.

[10] Ding Jie, Liu Hongjiao, Huang Xin, et al. Clinical manifestations of sarcopenia in maintenance hemodialysis patients and its relationship with TNF-α gene polymorphism. Chinese Journal of Integrated Traditional Chinese and Western Medicine Nephrology, 2021, 22(8): 725-727.

[11] Wang Yutao, Liu Juan. The relationship between serums IL-6, Cys C, TNF-α and sarcopenia in patients with chronic kidney disease and their impact on the risk of mortality. Journal of Kunming Medical University, 2024, 45(10): 85-90.

[12] Aragno M, Mastrocola R, Catalano MG. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes, 2004, 53(4): 1082.

[13] Scicchitano BM, Pelosi L, Sica G. The physiopathologic role of oxidative stress in skeletal muscle. Mech Ageing Dev, 2018, 170: 37-44.

[14] Bazzocchi A, Ponti F, Diano D, et al. Trabecular bone score in healthy ageing. Br J Radiol, 2015, 88(1052): 20140865.

[15] Cui Mengzhao. Analysis of clinical characteristics of myopenia in patients with type 2 diabetes [D]. Jilin University, 2018.

[16] Deutz NEP, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clinical Nutrition, 2014, 33(6): 929-936.

[17] He Qinghua, Sun Mingxiao, Yue Yanfen, et al. Metabolic characteristics and dietary analysis of elderly patients with diabetes myopenia. Chinese Journal of Geriatrics, 2019, 38(5): 552-557.

[18] Xu Youduan, Cai Wenwei, Chen Yi, et al. Study on the correlation between sarcopenia and nutritional status of elderly population in some communities in Shanghai. Chinese Journal of Clinical Health, 2022, 25(5): 605-609.

[19] Yang Xiaode, Jiang Lanlan, Xie Xiaojing. Effect of hemoglobin level on myopenia in patients with type 2 diabetes. Central South Journal of Medical Sciences, 2022, 50(3): 398-401.

[20] LAN Zhigang. Analysis of the impact of dietary and nutritional adjustments on the efficacy and safety of elderly patients with type 2 diabetes mellitus. Chinese Journal of Modern Drug Application, 2024, 18(19): 160-163.

[21] Ju SY, Lee JY, Kim DH. Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis. BMC Geriatr, 2018, 18(1): 206.

[22] Liu C, Ji Z, et al. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in sarcopenic older adults: A double-blind randomized controlled trial. Clin Nutr, 2019, 38(1): 159-164.

[23] Working group on the "Guidelines for Diagnosis and Treatment of Osteoporosis in the Elderly in China (2023)", Osteoporosis Branch of the Chinese Society of Gerontology and Geriatrics, Osteoporosis Branch of the Chinese Association for the Promotion of International Exchange in Healthcare, et al. Guidelines for Diagnosis and Treatment of Osteoporosis in the Elderly in China (2023). Chinese Journal of Orthopedics and Joint Surgery, 2023, 16(10): 865-885.

[24] Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 2017, 171(2): 273-285.

[25] Wang X, Fang X, Zheng W, et al. Genetic support of a causal relationship between iron status and type 2 diabetes: a Mendelian randomization study. J Clin Endocrinol Metab, 2021, 106(11): e4641-e4651.

[26] Guglielmi G, Ponti F, Agostini M, et al. The role of DXA in sarcopenia. Aging Clin Exp Res, 2016, 28(6): 1047-1060.

[27] Bazzocchi A, Ponti F, Diano D, et al. Trabecular bone score in healthy ageing. Br J Radiol, 2015, 88(1052): 20140865.

[28] Chen Xiaoqin, Zhong Weihong, Ye Jiajia, et al. A multicenter randomized controlled trial of traditional Chinese medicine rehabilitation therapy for knee osteoarthritis in middle-aged and elderly patients. Traditional Chinese Medicine Rehabilitation, 2024, 1(12): 1-6.

[29] Yan Meiqing, Xu Wentan, Wu Qiaoping. Effects of TPF-D on glucose and lipid metabolism, peripheral immune function and nutritional status in elderly patients with type 2 diabetes. North Pharmaceutical Journal, 2024, 21(06): 109-111.

[30] Wang Jianli, Zhou Lin, Xiao Xiaoling, et al. Efficacy of Shakubatrivarsartan combined with Dagelin in patients with heart failure without diabetes with reduced ejection fraction. Journal of Xi'an Jiaotong University (Medical Edition), 2023, 44(3): 415-420.